Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Just remain patient...noteable says so

<< Previous

Bullboard Posts

Next >>

Comment by Lesalpes29on Nov 01, 2022 6:14am

149 Views

Post# 35062104

RE:RE:RE:Just remain patient...noteable says so

Hcallahan44 wrote: yea and guys who have been around for soooooo long....and know sooooo much havent made squat....and wont

It’s a possibility for sure. But I am asking myself this : why on heart Misters Parsons And Rigby would be part of a loser? I Think the opposite here where I am. Flip a coin Mr big mouth and maybe you could just close it until November 7th! But of course you can’t because you are here to bash bash and bash! Do your job dummy! GLTA

<< Previous

Bullboard Posts

Next >>

Catch up with companies that got a Stanley Cup Playoffs boost